Armistice Capital, LLC 13D and 13G filings for Madrigal Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 2:50 pm Sale |
2023-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Armistice Capital, LLC | 50,000 0.250% |
-158,000 (-75.96%) |
Filing |
| 2023-02-14 1:05 pm Sale |
2022-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Armistice Capital, LLC | 208,000 1.210% |
-916,000 (-81.49%) |
Filing |
| 2022-02-14 6:31 pm Purchase |
2021-12-31 | 13G | Madrigal Pharmaceuticals, Inc. MDGL |
Armistice Capital, LLC | 1,124,000 6.600% |
1,124,000 (New Position) |
Filing |